Takeda Pharmaceutical Co Ltd (TAK) stock has fallen -0.66% over the last 12 months, and the average rating from Wall Street analysts is a Buy. InvestorsObserver’s proprietary ranking system, gives TAK stock a score of 33 out of a possible 100.
That rank is chiefly influenced by a short-term technical score of 27. TAK's rank also includes a long-term technical score of 46. TAK has an Overall Score of 33. Find out what this means to you and get the rest of the rankings on TAK!